EKTA-BElekta AB (publ)
56.30SEK-0.27%Mkt Cap: 21.21B SEKP/E: Last update: 2026-05-13

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accele…

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)
P/E (Forward)11.44
PEG0.29
P/B2.66
P/S1.24
EV/EBITDA17.14
EV/Revenue1.52
EPS (TTM)-0.10
EPS (Forward)4.85
Cash Flow & Leverage
FCF Yield4.90%
FCF Margin6.07%
Operating CF2.63B SEK
CapEx (TTM)1.57B SEK
Net Debt/EBITDA3.13
Net Debt4.74B SEK
Technical
SMA 5055.99 (+0.5%)
SMA 20053.07 (+6.1%)
Beta0.96
S&P 52W Chg24.23%
Avg Vol (30d)1.03M
Avg Vol (10d)894.64K
Technical Indicators
RSI (14)52.4
MACD0.1064
MACD Signal-0.0981
MACD Hist.+0.2045
BB Upper58.43 SEK
BB Middle55.84 SEK
BB Lower53.25 SEK
BB Width9.27%
ATR (14)1.407 SEK
Vol Ratio (20d)0.59x
52W Range
40.6460% of range66.70
52W High66.70 SEK
52W Low40.64 SEK
Profitability
Gross Margin37.44%
EBITDA Margin8.86%
Profit Margin1.32%
Oper. Margin6.60%
ROE2.69%
ROA0.82%
Revenue Growth-9.70%
Earnings Growth-97.10%
Balance Sheet
Debt/Equity0.86
Current Ratio0.95
Quick Ratio0.73
Book Value/Sh20.86 SEK
Cash/Share6.650 SEK
Dividends
Fwd Div Rate2.400 SEK
Trail. Div Rate2.400 SEK
Div. Yield4.32%
5Y Avg Yield3.27%
Payout Ratio315.79%
Ex-Div DateMar 5, 2026
Pay Date
Splits
Last Split4:1
Split DateSep 12, 2012
Ownership
Shares Out.367.10M
Float318.70M
Insiders5.99%
Institutions67.36%
Analyst Consensus
Rating
Target (Mean)58.29 SEK
Target Range39.00 SEK100.00 SEK
# Analysts14
Company
Market Cap21.21B SEK
Enterprise Value25.99B SEK
Revenue (TTM)17.11B SEK
Gross Profit6.75B SEK
Net Income (TTM)237.00M SEK
Revenue/Share44.78 SEK
Fiscal Year EndApr 2025
MR QuarterJan 2026
Employees4.4K
Last Price56.30 SEK
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINUS28617Y1010